163 related articles for article (PubMed ID: 30333121)
1. Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells.
Kabrani E; Chu VT; Tasouri E; Sommermann T; Baßler K; Ulas T; Zenz T; Bullinger L; Schultze JL; Rajewsky K; Sander S
Blood; 2018 Dec; 132(25):2670-2683. PubMed ID: 30333121
[TBL] [Abstract][Full Text] [Related]
2. Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.
Sander S; Calado DP; Srinivasan L; Köchert K; Zhang B; Rosolowski M; Rodig SJ; Holzmann K; Stilgenbauer S; Siebert R; Bullinger L; Rajewsky K
Cancer Cell; 2012 Aug; 22(2):167-79. PubMed ID: 22897848
[TBL] [Abstract][Full Text] [Related]
3. Sporadic and endemic Burkitt lymphoma have frequent
Zhou P; Blain AE; Newman AM; Zaka M; Chagaluka G; Adlar FR; Offor UT; Broadbent C; Chaytor L; Whitehead A; Hall A; O'Connor H; Van Noorden S; Lampert I; Bailey S; Molyneux E; Bacon CM; Bomken S; Rand V
Blood Adv; 2019 Jul; 3(14):2118-2127. PubMed ID: 31300419
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the transcription factor FOXO1 mimic positive selection signals to promote germinal center B cell expansion and lymphomagenesis.
Roberto MP; Varano G; Vinas-Castells R; Holmes AB; Kumar R; Pasqualucci L; Farinha P; Scott DW; Dominguez-Sola D
Immunity; 2021 Aug; 54(8):1807-1824.e14. PubMed ID: 34380064
[TBL] [Abstract][Full Text] [Related]
5. Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells.
Sander S; Rajewsky K
Oncotarget; 2012 Oct; 3(10):1066-7. PubMed ID: 23164662
[No Abstract] [Full Text] [Related]
6. AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.
Pan CW; Jin X; Zhao Y; Pan Y; Yang J; Karnes RJ; Zhang J; Wang L; Huang H
EMBO J; 2017 Apr; 36(8):995-1010. PubMed ID: 28279977
[TBL] [Abstract][Full Text] [Related]
7. Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma.
Gehringer F; Weissinger SE; Möller P; Wirth T; Ushmorov A
Leukemia; 2020 Mar; 34(3):857-871. PubMed ID: 31719683
[TBL] [Abstract][Full Text] [Related]
8. The AKT isoforms 1 and 2 drive B cell fate decisions during the germinal center response.
Zhu Z; Shukla A; Ramezani-Rad P; Apgar JR; Rickert RC
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31767615
[TBL] [Abstract][Full Text] [Related]
9. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.
Zhang N; Qiu J; Zheng T; Zhang X; Hua K; Zhang Y
Oncol Rep; 2018 Mar; 39(3):1034-1042. PubMed ID: 29286125
[TBL] [Abstract][Full Text] [Related]
10. UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.
Bedekovics T; Hussain S; Feldman AL; Galardy PJ
Blood; 2016 Mar; 127(12):1564-74. PubMed ID: 26702068
[TBL] [Abstract][Full Text] [Related]
11. c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma.
Scheller H; Tobollik S; Kutzera A; Eder M; Unterlehberg J; Pfeil I; Jungnickel B
Oncogene; 2010 Feb; 29(6):888-97. PubMed ID: 19881537
[TBL] [Abstract][Full Text] [Related]
12. Leucine promotes differentiation of porcine myoblasts through the protein kinase B (Akt)/Forkhead box O1 signalling pathway.
Zhang S; Chen X; Huang Z; Chen D; Yu B; Chen H; Luo J; He J; Zheng P; Yu J
Br J Nutr; 2018 Apr; 119(7):727-733. PubMed ID: 29569540
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.
Schneider C; Setty M; Holmes AB; Maute RL; Leslie CS; Mussolin L; Rosolen A; Dalla-Favera R; Basso K
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8185-90. PubMed ID: 24843176
[TBL] [Abstract][Full Text] [Related]
14. Serine-threonine kinase ROCK2 regulates germinal center B cell positioning and cholesterol biosynthesis.
Ricker E; Chinenov Y; Pannellini T; Flores-Castro D; Ye C; Gupta S; Manni M; Liao JK; Pernis AB
J Clin Invest; 2020 Jul; 130(7):3654-3670. PubMed ID: 32229726
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large B-cell lymphoma.
Go H; Jang JY; Kim PJ; Kim YG; Nam SJ; Paik JH; Kim TM; Heo DS; Kim CW; Jeon YK
Oncotarget; 2015 Jun; 6(17):15035-49. PubMed ID: 25909227
[TBL] [Abstract][Full Text] [Related]
16. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins.
Aoki M; Jiang H; Vogt PK
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13613-7. PubMed ID: 15342912
[TBL] [Abstract][Full Text] [Related]
17. The Nuclear Zinc Finger Protein Zfat Maintains FoxO1 Protein Levels in Peripheral T Cells by Regulating the Activities of Autophagy and the Akt Signaling Pathway.
Ishikura S; Iwaihara Y; Tanaka Y; Luo H; Nishi K; Doi K; Koyanagi M; Okamura T; Tsunoda T; Shirasawa S
J Biol Chem; 2016 Jul; 291(29):15282-91. PubMed ID: 27226588
[TBL] [Abstract][Full Text] [Related]
18. Evidence for AKT-independent regulation of FOXO1 and FOXO3 in haematopoietic stem and progenitor cells.
Liang R; Rimmelé P; Bigarella CL; Yalcin S; Ghaffari S
Cell Cycle; 2016; 15(6):861-7. PubMed ID: 26929388
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.
Giulino-Roth L; van Besien HJ; Dalton T; Totonchy JE; Rodina A; Taldone T; Bolaender A; Erdjument-Bromage H; Sadek J; Chadburn A; Barth MJ; Dela Cruz FS; Rainey A; Kung AL; Chiosis G; Cesarman E
Mol Cancer Ther; 2017 Sep; 16(9):1779-1790. PubMed ID: 28619753
[TBL] [Abstract][Full Text] [Related]
20. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
